MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 338 filers reported holding MEDIVATION INC in Q4 2014. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $603,000 | +31.1% | 10,000 | 0.0% | 0.10% | +26.6% |
| Q1 2016 | $460,000 | -4.8% | 10,000 | 0.0% | 0.08% | +5.3% |
| Q4 2015 | $483,000 | +13.6% | 10,000 | 0.0% | 0.08% | +7.1% |
| Q3 2015 | $425,000 | -84.2% | 10,000 | -57.6% | 0.07% | -82.8% |
| Q2 2015 | $2,691,000 | -56.4% | 23,560 | -50.7% | 0.41% | -53.0% |
| Q1 2015 | $6,173,000 | +33.9% | 47,824 | +3.3% | 0.86% | +28.8% |
| Q4 2014 | $4,610,000 | -5.9% | 46,283 | -6.6% | 0.67% | -10.5% |
| Q3 2014 | $4,901,000 | +118.4% | 49,566 | +70.2% | 0.75% | +126.6% |
| Q2 2014 | $2,244,000 | -13.8% | 29,114 | -28.0% | 0.33% | -12.7% |
| Q1 2014 | $2,603,000 | -0.8% | 40,432 | -1.7% | 0.38% | +2.2% |
| Q4 2013 | $2,624,000 | -18.4% | 41,111 | -23.4% | 0.37% | -24.0% |
| Q3 2013 | $3,217,000 | +735.6% | 53,663 | +585.2% | 0.49% | +617.6% |
| Q2 2013 | $385,000 | – | 7,832 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |